Published in Diabetes Care on February 11, 1985
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
The long and winding road to optimal HbA1c measurement. Clin Chim Acta (2013) 0.91
Crystallization and preliminary crystallographic analysis of human glycosylated haemoglobin. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.76
Glycated haemoglobin values. Methodological discrepancies are not important. BMJ (1994) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 16.65
A gene map of the human genome. Science (1996) 14.32
Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 10.01
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1998) 9.56
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34
Choice behavior and the accessibility of the reinforcer. J Exp Anal Behav (1972) 6.14
Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science (1988) 5.71
Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem (1996) 5.15
An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A (1996) 4.57
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer (1983) 4.33
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
The glycosylation of hemoglobin: relevance to diabetes mellitus. Science (1978) 3.87
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
Neonatal leptin treatment reverses developmental programming. Endocrinology (2005) 3.51
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res (1994) 3.20
Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem (2000) 3.17
Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem (1968) 3.09
The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest (1976) 3.00
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Third molar surgery: an audit of the indications for surgery, post-operative complaints and patient satisfaction. Br J Oral Maxillofac Surg (1995) 2.89
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Randomised trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring. Lancet (1992) 2.88
Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature (1992) 2.88
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85
Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab (1977) 2.84
MEASUREMENT OF SMALL QUANTITIES OF INSULIN-LIKE ACTIVITY USING RAT ADIPOSE TISSUE. II. EVALUATION OF PERFORMANCE. J Clin Invest (1960) 2.63
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage phi 29. J Mol Biol (1987) 2.59
The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A (1987) 2.51
Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun (1975) 2.46
Preventive care: do we practice what we preach? Am J Public Health (1987) 2.44
The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem (1996) 2.42
Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood (1991) 2.41
Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest (1993) 2.40
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene (2001) 2.36
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem (1986) 2.36
A computer analysis of serial interactions in spaced responding. J Exp Anal Behav (1966) 2.34
Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol (2000) 2.33
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
No to BDA. Br Dent J (2010) 2.31
Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome. Cell (1985) 2.28
Conservative treatment of cutis aplasia. Plast Reconstr Surg (1990) 2.27
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J (1997) 2.25
Audit of bone marrow trephines. J Clin Pathol (1992) 2.24
Causal explanations as a risk factor for depression: theory and evidence. Psychol Rev (1984) 2.24
Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem (1991) 2.22
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry (1995) 2.19
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. JAMA (1971) 2.17
Evidence for multi-site closure of the neural tube in humans. Am J Med Genet (1993) 2.16
Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens. AIDS (2001) 2.15
Mutation rates in cells at different ploidy levels. J Cell Physiol (1971) 2.11
Regulation of the erythropoietin gene. Blood (1999) 2.10
Oral submucous fibrosis: its pathogenesis and management. Br Dent J (1986) 2.09
Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology (1999) 2.07
Interrater reliability of roentgenological evaluation of the lumbar spine in lateral bending. J Manipulative Physiol Ther (1990) 2.04
A survey of dental hygienists in the United Kingdom in 2011. Part 1--demographics and working patterns as dental hygienists. Br Dent J (2012) 2.04
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest (1993) 2.03
Morphological and immunophenotypic variations in malignant melanoma. Histopathology (2000) 2.02
Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): continuing diagnostic difficulties. Histopathology (1998) 2.01
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2001) 1.99
Effect of glycosylation on the in vivo circulating half-life of ribonuclease. J Biol Chem (1976) 1.97
Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry (1995) 1.97
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood (1992) 1.97
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.95
Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol (1992) 1.94
Acute subdural hematoma: morbidity, mortality, and operative timing. J Neurosurg (1991) 1.93
Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet (1994) 1.90
Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem (1979) 1.89
Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9. Proc Natl Acad Sci U S A (1993) 1.88
Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell (1982) 1.85
Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem (1995) 1.84
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Exchange of heme among hemoglobin molecules. Proc Natl Acad Sci U S A (1966) 1.81
The interaction of 2,3-diphosphoglycerate with various human hemoglobins. J Clin Invest (1970) 1.81
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81
Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem (1984) 1.80
Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol (1998) 1.80
The incidence of schizophrenia in Nottingham. Br J Psychiatry (1987) 1.79
Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J (1999) 1.76
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry (1991) 1.75
Tropomyosin isoform switching in tumorigenic human fibroblasts. Mol Cell Biol (1986) 1.75
Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol (1993) 1.74
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J Virol (1998) 1.72
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer (1984) 1.70
A study on the transcription of the polyoma viral genome. Proc Natl Acad Sci U S A (1970) 1.67
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev (2006) 1.66
Regulation of erythrocyte cation and water content in sickle cell anemia. Science (1986) 1.65
Evaluation of glycosylated hemoglobin diabetic patients. Diabetes (1981) 1.65
Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology (1992) 1.63
A randomized clinical trial of supported employment for inner-city patients with severe mental disorders. Arch Gen Psychiatry (1999) 1.63
Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids (2003) 1.62
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons. J Infect Dis (2001) 1.62
Klippel-Trenaunay syndrome. Am J Med Genet (1998) 1.62